SUGEAK owner Contact Information online
from SANOFI
SUGEAK
US serial number:85081132
Application filling date:Jul. 09, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Aug. 09, 2011
Publication date:May 24, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign priority claimed:Yes
Foreign foreign application number:103717379
Foreign foreign application filling date:Feb. 26, 2010
Foreign foreign registration number:103717379
Foreign foreign registration date:Feb. 26, 2010
Foreign foreign application registration country:FRANCE
Foreign foreign expiration date:Feb. 26, 2020
Goods and services:For: pharmaceutical preparations for the prevention and treatment of cancer
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 44(e)
Services:pharmaceutical preparations for the prevention and treatment of cancer
Current owner owner name:SANOFI
Current owner owner address:174, avenue de France
Paris
FRANCE
75013
Current owner legal entity type:SOCIETE ANONYME
Current owner state or country:FRANCE
Attorney name:Susan Upton Douglass
Attorney email:sdouglass@fzlz.com
Attorney docket number:SYN 1004936
Attorney email authorized:No
Correspondent name address:SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK,
NEW YORK
UNITED STATES
10017
Correspondent phone:212-813-5900
Correspondent email:sdouglass@fzlz.com
Correspondent fax:212-813-5901
Correspondent email authorized:No
Domestic representative name:Susan Upton Douglass
Domestic representative phone:212-813-5900
Domestic representative fax:212-813-5901
Domestic representative email:sdouglass@fzlz.com
Domestic representative email authorized SUGEAK:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (126) SANOFI (60) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (20) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
May 24, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Apr. 19, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Feb. 22, 2011 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Nov. 23, 2010 Sep. 28, 2010
